Colchicine, aspirin, and montelukast – A case of successful combined pharmacotherapy for adult multisystem inflammatory syndrome in COVID-19
Since the beginning of the COVID-19 pandemic, many therapeutic strategies have been tried, with mixed results, to prevent and treat adult multisystem inflammatory syndrome in COVID-19 (AMIS-COVID-19). The reason behind this may the complex web of highly intertwined pathophysiologic mechanisms involv...
Main Authors: | Sean Downing, Vivek Chauhan, Irshad H Chaudry, Sagar Galwankar, Pushpa Sharma, Stanislaw P Stawicki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Global Infectious Diseases |
Subjects: | |
Online Access: | http://www.jgid.org/article.asp?issn=0974-777X;year=2020;volume=12;issue=4;spage=221;epage=224;aulast=Downing |
Similar Items
-
Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study
by: Tariq Kewan, et al.
Published: (2020-07-01) -
The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis
by: Roshan Kumar Mahat, et al.
Published: (2021-07-01) -
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
by: Luigi Brunetti, et al.
Published: (2020-09-01) -
Multisystemic Infarctions in COVID-19: Focus on the Spleen
by: Mariana Santos Leite Pessoa, et al.
Published: (2020-06-01) -
Immunological and Clinical Aspects of Immune Responses to SARS-CoV-2
by: Ali Reza Andalib, et al.
Published: (2021-03-01)